ReviewAdvanced genetics (Hoboken, N.J.)2025
From Genomic Fossils to Functional Elements: The Evolving Story of Pseudogenes.
Review in Advanced genetics (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Non-coding RNAs in peripheral vascular diseases - a snRNA study.Journal of applied genetics · 2026Article
- Comparative chloroplast genomes of Hamamelidaceae: genome evolution and phylogenomic implications.BMC plant biology · 2026Article
- From Genomic Fossils to Functional Elements: The Evolving Story of Pseudogenes.Advanced genetics (Hoboken, N.J.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudogenes, as important products of genomic evolution, play unique regulatory roles in species adaptation. This review systematically summarizes the major types, functions, and regulatory mechanisms of metazoans pseudogenes, with a particular focus on their formation during primate evolution and the mechanisms underlying their retention in the human genome. Previous studies suggest that the loss of function in pseudogenes releases selective pressure, allowing them to evolve neutrally; furthermore, their latent functional or adaptive potential, such as reactivation, neofunctionalization, or evolutionary advantages conferred by gene silencing, further promotes their persistence. For instance, the integration of certain pseudogenes can introduce novel regulatory functions, while pseudogenization-induced gene inactivation may also provide selective benefits. Recent technological advances, including long-read sequencing, single-cell omics, and CRISPR-based functional interrogation, have greatly expanded our understanding of pseudogenes. We propose that pseudogene-mediated regulation plays a critical role in evolutionary processes and highlight their dynamic roles in both physiological and pathological contexts. We further discuss current research progress, limitations, and future directions, offering new perspectives for understanding genomic evolution and biomedical significance of pseudogenes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.